These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12499181)

  • 21. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
    Kozawa O; Uematsu T; Matsuno H; Niwa M; Nagashima S; Kanamaru M
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2824-8. PubMed ID: 9124849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of food and gastric pH on the bioavailability of grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():18-24. PubMed ID: 9433652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
    Yamaguchi H; Yano I; Saito H; Inui K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grepafloxacin concentration in ocular tissues after intravenous infusion in rabbits with intraocular inflammation.
    Pérez-Oliván S; Pinilla I; Bregante MA; Solans C; Ruiz Moreno O; Garcia MA; Honrubia FM
    Ophthalmic Res; 2005; 37(6):335-40. PubMed ID: 16158011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of quinolone antibiotics in rats: efflux from cerebrospinal fluid to the circulation.
    Ooie T; Suzuki H; Terasaki T; Sugiyama Y
    Pharm Res; 1996 Jul; 13(7):1065-8. PubMed ID: 8842046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo.
    Sande MA; Korzeniowski OM; Allegro GM; Brennan RO; Zak O; Scheld WM
    Rev Infect Dis; 1981; 3(1):98-109. PubMed ID: 7221361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
    Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat.
    Sasabe H; Kato Y; Terasaki T; Tsuji A; Sugiyama Y
    Biopharm Drug Dispos; 1999 Apr; 20(3):151-8. PubMed ID: 10211868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits.
    Krontz DP; Strausbaugh LJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):882-6. PubMed ID: 7235677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis.
    Scotton PG; Pea F; Giobbia M; Baraldo M; Vaglia A; Furlanut M
    Clin Infect Dis; 2001 Nov; 33(9):e109-11. PubMed ID: 11577376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative arthropathy of fluoroquinolones in dogs.
    Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.
    Ito T; Yano I; Masuda S; Hashimoto Y; Inui K
    Pharm Res; 1999 Apr; 16(4):534-9. PubMed ID: 10227708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
    Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
    J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.
    Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Wong FA; Corrado M
    Antimicrob Agents Chemother; 1998 May; 42(5):1098-104. PubMed ID: 9593134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.